{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:20:28Z","timestamp":1774675228499,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s10840-012-9767-1","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:25:43Z","timestamp":1356002743000},"page":"99-105","source":"Crossref","is-referenced-by-count":12,"title":["FDA regulation of cardiovascular devices and opportunities for improvement"],"prefix":"10.1007","volume":"36","author":[{"given":"Sanket S.","family":"Dhruva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita F.","family":"Redberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"9767_CR1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","volume":"34","author":"HG Mond","year":"2011","unstructured":"Mond, H. G., & Proclemer, A. (2011). The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009\u2014a world society of arrhythmia\u2019s project. PACE, 34, 1013\u20131027.","journal-title":"PACE"},{"issue":"3","key":"9767_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMp020170","volume":"348","author":"DW Feigal","year":"2003","unstructured":"Feigal, D. W., Gardner, S. N., & McClellan, M. (2003). Ensuring safe and effective medical devices. The New England Journal of Medicine, 348(3), 191\u2013192.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR3","volume-title":"Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products","author":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)","year":"1998","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). (1998). Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products. Rockville: CDER and CBER."},{"issue":"13","key":"9767_CR4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMp1000447","volume":"362","author":"AM Garber","year":"2010","unstructured":"Garber, A. M. (2010). Modernizing device regulation. The New England Journal of Medicine, 362(13), 1161\u20131163.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR5","unstructured":"Food, Drug, and Cosmetic Act. 21 USC \u00a7 201(h). http:\/\/www.fda.gov\/RegulatoryInformation\/Legislation\/FederalFoodDrugandCosmeticActFDCAct\/ . Accessed 19 Nov 2012."},{"key":"9767_CR6","unstructured":"The Least Burdensome Provisions of the FDA Modernization Act of 1997: Concept and Principles; Final Guidance for FDA and Industry. http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/ucm085994.htm . Accessed 19 Nov 2012."},{"key":"9767_CR7","unstructured":"Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. Guidance for Industry and Food and Drug Administration Staff Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications. March 28, 2012. http:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM296379.pdf . Accessed 19 Nov 2012."},{"key":"9767_CR8","unstructured":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. Device Classes. http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/Overview\/GeneralandSpecialControls\/default.htm . Accessed 19 Nov 2012."},{"key":"9767_CR9","unstructured":"US Government Accountability Office. FDA should take steps to ensure that high-risk device types are approved through the most stringent premarket review process: GAO-09-190: January 2009. http:\/\/gao.gov\/new.items\/d09190.pdf . Accessed 19 Nov 2012."},{"key":"9767_CR10","unstructured":"U.S. Food and Drug Administration. Medical Devices: Premarket Notification (510\u00a0k). http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/HowtoMarketYourDevice\/PremarketSubmissions\/PremarketNotification510k\/default.htm . Accessed 19 Nov 2012."},{"issue":"2","key":"9767_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12265-009-9096-7","volume":"2","author":"EA Chen","year":"2009","unstructured":"Chen, E. A., Patel-Raman, S. M., O\u2019Callaghan, K., & Hillebrenner, M. G. (2009). FDA\u2019s perspectives on cardiovascular devices. Journal of Cardiovascular Translational Research, 2(2), 143\u2013146.","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"9767_CR12","unstructured":"U.S. Food and Drug Administration. Medical Devices: PMA Application Contents. http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/HowtoMarketYourDevice\/PremarketSubmissions\/PremarketApprovalPMA\/ucm050289.htm . Accessed 19 Nov 2012."},{"issue":"2","key":"9767_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2009.973","volume":"302","author":"AB O\u2019Connor","year":"2009","unstructured":"O\u2019Connor, A. B. (2009). The need for improved access to FDA reviews. JAMA: The Journal of the American Medical Association, 302(2), 191\u2013193.","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"9767_CR14","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMp1005202","volume":"362","author":"AK Asamoah","year":"2010","unstructured":"Asamoah, A. K., & Sharfstein, J. M. (2010). Transparency at the food and drug administration. The New England Journal of Medicine, 362, 2341\u20132343.","journal-title":"The New England Journal of Medicine"},{"issue":"20","key":"9767_CR15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/archinternmed.2010.323","volume":"170","author":"RF Redberg","year":"2010","unstructured":"Redberg, R. F. (2010). Medical devices and the FDA approval process: balancing safety and innovation; comment on \u201cPrevalence of fracture and fragment embolization of bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade\u201d. Archives of Internal Medicine, 170(20), 1831\u20131833.","journal-title":"Archives of Internal Medicine"},{"issue":"20","key":"9767_CR16","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1001\/archinternmed.2010.316","volume":"170","author":"W Nicholson","year":"2010","unstructured":"Nicholson, W., Nicholson, W. J., Tolerico, P., Taylor, B., Solomon, S., Schryver, T., McCullum, K., Goldberg, H., Mills, J., Schuler, B., Shears, L., Siddoway, L., Agarwal, N., & Tuohy, C. (2010). Prevalence of fracture and fragment embolization of bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade. Archives of Internal Medicine, 170(20), 1827\u20131831.","journal-title":"Archives of Internal Medicine"},{"key":"9767_CR17","unstructured":"Food and Drug Administration. Removing Retrievable Inferior Vena Cava Filters: Initial Communication. August 9, 2010. http:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm221676.htm . Accessed 19 Nov 2012."},{"key":"9767_CR18","volume-title":"Medical devices and the public\u2019s health: the FDA 510(k) clearance process at 35\u00a0years","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine. (2011). Medical devices and the public\u2019s health: the FDA 510(k) clearance process at 35\u00a0years. Washington: National Academies Press."},{"key":"9767_CR19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMp1109150","volume":"365","author":"DR Challoner","year":"2011","unstructured":"Challoner, D. R., & Vodra, W. W. (2011). Medical devices and health\u2014creating a new regulatory framework for moderate-risk devices. The New England Journal of Medicine, 365, 977\u2013979.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMp1109094","volume":"365","author":"GD Curfman","year":"2011","unstructured":"Curfman, G. D., & Redberg, R. F. (2011). Medical devices\u2014balancing regulation and innovation. The New England Journal of Medicine, 365, 975\u2013977.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/archinternmed.2011.27","volume":"171","author":"RF Redberg","year":"2011","unstructured":"Redberg, R. F., & Dhruva, S. S. (2011). Medical device recalls: get it right the first time: comment on \u201cMedical device recalls and the FDA approval process\u201d. Archives of Internal Medicine, 171, 1011\u20131012.","journal-title":"Archives of Internal Medicine"},{"key":"9767_CR22","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1001\/jama.2009.1899","volume":"302","author":"SS Dhruva","year":"2009","unstructured":"Dhruva, S. S., Bero, L. A., & Redberg, R. F. (2009). Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. JAMA: The Journal of the American Medical Association, 302, 2679\u20132685.","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"9","key":"9767_CR23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.7326\/0003-4819-149-9-200811040-00004","volume":"149","author":"E Lim","year":"2008","unstructured":"Lim, E., Brown, A., Helmy, A., Mussa, S., & Altman, D. G. (2008). Composite outcomes in cardiovascular research: a survey of randomized trials. Annals of Internal Medicine, 149(9), 612\u2013617.","journal-title":"Annals of Internal Medicine"},{"key":"9767_CR24","unstructured":"Makower J, Meer A, Denend L. FDA Impact on U.S. Medical technology innovation: a survey of over 200 medical technology companies. November 2010."},{"key":"9767_CR25","doi-asserted-by":"crossref","first-page":"d2748","DOI":"10.1136\/bmj.d2748","volume":"342","author":"D Cohen","year":"2011","unstructured":"Cohen, D., & Billingsley, M. (2011). Europeans are left to their own devices. BMJ, 342, d2748.","journal-title":"BMJ"},{"issue":"6","key":"9767_CR26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archinternmed.2010.445","volume":"171","author":"CE Chen","year":"2011","unstructured":"Chen, C. E., Dhruva, S. S., Bero, L. A., & Redberg, R. F. (2011). Inclusion of training patients in US food and drug administration premarket approval cardiovascular device studies. Archives of Internal Medicine, 171(6), 534\u2013539.","journal-title":"Archives of Internal Medicine"},{"key":"9767_CR27","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMp0903763","volume":"360","author":"WB Maisel","year":"2009","unstructured":"Maisel, W. B. (2009). Left atrial appendage occlusion\u2014closure or just the beginning? The New England Journal of Medicine, 360, 2601\u20132603.","journal-title":"The New England Journal of Medicine"},{"issue":"19","key":"9767_CR28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.2011.1675","volume":"306","author":"MJ Mack","year":"2011","unstructured":"Mack, M. J., & Holmes, D. R. (2011). Rational dispersion for the introduction of transcatheter valve therapy. JAMA: The Journal of the American Medical Association, 306(19), 2149\u20132150.","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"9767_CR29","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMp1009686","volume":"363","author":"S Okie","year":"2010","unstructured":"Okie, S. (2010). Reviving the FDA. The New England Journal of Medicine, 363, 1492\u20131494.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archinternmed.2011.30","volume":"171","author":"DM Zuckerman","year":"2011","unstructured":"Zuckerman, D. M., Brown, P., & Nissen, S. E. (2011). Medical device recalls and the FDA approval process. Archives of Internal Medicine, 171, 1006\u20131011.","journal-title":"Archives of Internal Medicine"},{"key":"9767_CR31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMp0800495","volume":"358","author":"WH Maisel","year":"2008","unstructured":"Maisel, W. H. (2008). Semper fidelis\u2014consumer protection for patients with implanted medical devices. The New England Journal of Medicine, 358, 985\u2013987.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.110.991075","volume":"123","author":"RW Yeh","year":"2011","unstructured":"Yeh, R. W., Kennedy, K., Spertus, J. A., Parikh, S. A., Sakhuja, R., Anderson, H. V., White, C. J., & Rosenfield, K. (2011). Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting. Circulation, 123, 1384\u20131390.","journal-title":"Circulation"},{"key":"9767_CR33","doi-asserted-by":"crossref","first-page":"c4753","DOI":"10.1136\/bmj.c4753","volume":"341","author":"J Lenzer","year":"2010","unstructured":"Lenzer, J., & Brownlee, S. (2010). Why the FDA can\u2019t protect the public. BMJ, 341, c4753.","journal-title":"BMJ"},{"key":"9767_CR34","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jama.294.8.955","volume":"294","author":"WH Maisel","year":"2005","unstructured":"Maisel, W. H. (2005). Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA: The Journal of the American Medical Association, 294, 955\u2013958.","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"9767_CR35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMp1114695","volume":"366","author":"RG Hauser","year":"2012","unstructured":"Hauser, R. G. (2012). Here we go again\u2014another failure of postmarketing device surveillance. The New England Journal of Medicine, 366, 873\u2013875.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR36","unstructured":"FDA Safety Communication: Premature insulation failure in recalled riata implantable cardioverter defibrillator (ICD) leads manufactured by St. Jude Medical, Inc. http:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm314930.htm . Accessed 19 Nov 2012."},{"key":"9767_CR37","unstructured":"US Government Accountability Office. FDA Should Enhance Its Oversight of Recalls. GAO-11-468. June 2011. www.gao.gov\/new.items\/d11468.pdf . Accessed 19 Nov 2012."},{"key":"9767_CR38","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2010.1633","volume":"304","author":"FS Resnic","year":"2010","unstructured":"Resnic, F. S., Gross, T. P., Marinac-Dabic, D., Loyo-Berrios, N., Donnelly, S., Normand, S. L., & Matheny, M. E. (2010). Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA: The Journal of the American Medical Association, 304, 2019\u20132027.","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"6","key":"9767_CR39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMp1014427","volume":"364","author":"RE Behrman","year":"2011","unstructured":"Behrman, R. E., Benner, J. S., Brown, J. S., McClellan, M., Woodcock, J., & Platt, R. (2011). Developing the sentinel system\u2014a national resource for evidence development. The New England Journal of Medicine, 364(6), 498\u2013499.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR40","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJMe0902377","volume":"360","author":"GD Curfman","year":"2009","unstructured":"Curfman, G. D., Morrissey, S., & Drazen, J. D. (2009). The medical device safety Act of 2009. The New England Journal of Medicine, 360, 1550\u20131551.","journal-title":"The New England Journal of Medicine"},{"key":"9767_CR41","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/jama.299.19.2313","volume":"299","author":"LO Gostin","year":"2008","unstructured":"Gostin, L. O. (2008). The deregulatory effects of preempting tort litigation: FDA regulation of medical devices. JAMA: The Journal of the American Medical Association, 299, 2313\u20132316.","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"9767_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCOUTCOMES.110.958215","volume":"4","author":"SS Dhruva","year":"2011","unstructured":"Dhruva, S. S., Bero, L. A., & Redberg, R. F. (2011). Gender bias in studies for food and drug administration premarket approval of cardiovascular devices. Circulation Cardiovascular Quality and Outcomes, 4, 165\u2013171.","journal-title":"Circulation Cardiovascular Quality and Outcomes"},{"key":"9767_CR43","unstructured":"Summary of Safety and Effectiveness. PMA 000009. Phylax AV ICD, Model 122 382, Software Cartridge SWMI\/I-GAV.2.U, Model 128 814. September 2000. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P000009b.pdf . Accessed 19 Nov 2012."},{"key":"9767_CR44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/ATVBAHA.108.179796","volume":"29","author":"ES Kim","year":"2009","unstructured":"Kim, E. S., & Menon, V. (2009). Status of women in cardiovascular clinical trials. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 279\u2013283.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9767_CR45","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/archinternmed.2009.255","volume":"169","author":"H Ghanbari","year":"2009","unstructured":"Ghanbari, H., Dalloul, G., Hasan, R., Daccarett, M., Saba, S., David, S., & Machado, C. (2009). Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Archives of Internal Medicine, 169, 1500\u20131506.","journal-title":"Archives of Internal Medicine"},{"key":"9767_CR46","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archinternmed.2009.261","volume":"169","author":"RF Redberg","year":"2009","unstructured":"Redberg, R. F. (2009). Is what is good for the gander really good for the goose? Archives of Internal Medicine, 169, 1460\u20131461.","journal-title":"Archives of Internal Medicine"},{"key":"9767_CR47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/CIRCULATIONAHA.108.793463","volume":"119","author":"PN Peterson","year":"2009","unstructured":"Peterson, P. N., Daugherty, S. L., Wang, Y., Vidaillet, H. J., Heidenreich, P. A., & Curtis, J. P. (2009). Masoudi FA on behalf of the national cardiovascular data registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation, 119, 1078\u20131084.","journal-title":"Circulation"},{"issue":"7","key":"9767_CR48","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2010.06.061","volume":"57","author":"A Arshad","year":"2011","unstructured":"Arshad, A., Moss, A. J., Foster, E., Padeletti, L., Barsheshet, A., Goldenberg, I., et al. (2011). Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) Trial. Journal of the American College of Cardiology, 57(7), 813\u2013820.","journal-title":"Journal of the American College of Cardiology"},{"key":"9767_CR49","unstructured":"Draft Guidance for Industry and Food and Drug Adminsitration Staff: Evaluation of Sex Differences in Medical Device Clinical Studies. http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/ucm283453.htm . Accessed 19 Nov 2012."},{"key":"9767_CR50","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1001\/jama.2010.1695","volume":"304","author":"SS Dhruva","year":"2010","unstructured":"Dhruva, S. S., & Redberg, R. F. (2010). Accelerated approval and possible withdrawal of midodrine. JAMA: The Journal of the American Medical Association, 304, 2172\u20132173.","journal-title":"JAMA: The Journal of the American Medical Association"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-012-9767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-012-9767-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-012-9767-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:04:08Z","timestamp":1559268248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-012-9767-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["9767"],"URL":"https:\/\/doi.org\/10.1007\/s10840-012-9767-1","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}